Anavex Life Sciences Corp. (AVXL) Q4 2025 Earnings
AVXL·Reported February 9, 2026·Before market open
Diluted EPS came in at $-0.06 (+57.1% YoY), beat the $-0.10 consensus by $0.04.
Diluted EPS
$-0.06beat by $0.04
Consensus: $-0.10
Financial Snapshot
Trailing eight quarters through Q4 2025
Q4 2025 Earnings FAQ
Common questions about Anavex Life Sciences Corp.'s Q4 2025 earnings report.
Anavex Life Sciences Corp. (AVXL) reported Q4 2025 earnings on February 9, 2026 before market open.
Anavex Life Sciences Corp. reported diluted EPS of $-0.06 for Q4 2025.
EPS beat the consensus estimate of $-0.10 by $0.04.
Compared to the same quarter a year prior, diluted EPS grew 57.1% from $-0.14.
You can read the 8-K earnings release (0001731122-26-000193) and the 10-Q periodic report (0001731122-26-000200) directly on SEC EDGAR. The filing index links above go to sec.gov.